United States

RSM helps biopharmaceutical company save IPO price

Rapid valuation response helps client finance its future


Download case study

A biopharmaceutical company had developed next generation cardiac and pulmonary therapies and was ready to move on to clinical trials in the U.S. and a product launch in Europe, but they were running out of cash. They had to complete an IPO – and quickly.

They turned to RSM. Under very tight deadlines, we:

  • completed nine different valuations
  • helped the client coordinate the process with their management, auditors and legal counsel
  • helped the client draft its S-1 and answer SEC queries

Learn more about how we helped this client move on with its IPO quickly and finance its future.

Contact our professionals

To discuss how our team can help your business, contact us by phone 800.274.3978 or